Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2006-07-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BMCL.2006.04.064PMID 16682185
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network

  2005cited by this paper
• Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3.

  2005cited by this paper
• Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs.

  2005cited by this paper
• A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists.

  2004cited by this paper
• Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720.

  2004cited by this paper
• FTY720: Sphingosine 1‐Phosphate Receptor‐1 in the Control of Lymphocyte Egress and Endothelial Barrier Function

  2004cited by this paper
• Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate*

  2004cited by this paper
• Expression of the Sphingosine 1-Phosphate Receptor, S1P1, on T-cells Controls Thymic Emigration*

  2004cited by this paper
• Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

  2004cited by this paper
• FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity.

  2002cited by this paper
• Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

  2002cited by this paper

• Sphingolipid-mediated calcium signaling and its pathological effects.

  2018cites this paper
• Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?

  2017cites this paper
• Pd-Catalyzed one-pot sequential cross-coupling reactions of tetrabromothiophene.

  2017cites this paper
• Discovery of a 1-Methyl-3,4-dihydronaphthalene-Based Sphingosine-1-Phosphate (S1P) Receptor Agonist Ceralifimod (ONO-4641). A S1P1 and S1P5 Selective Agonist for the Treatment of Autoimmune Diseases.

  2017cites this paper
• Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses.

  2016cites this paper
• Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonist for the Potential Treatment of Neurodegenerative Disorders.

  2015cites this paper
• Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal

  2015cites this paper
• Dérivés hétérocycliques à activité pesticide comportant des substituants contenant du soufre

  2015cites this paper
• Synthesis and In Vivo Anticonvulsant Activity of 2‐Methyl‐2‐[3‐(5‐piperazin‐1‐yl‐[1,3,4]oxadiazol‐2‐yl)‐phenyl]‐propionitrile Derivatives

  2014cites this paper
• Sphingosine-1-Phosphate Signaling in Immunology and Infectious Diseases

  2014cites this paper
• Optimization of sphingosine-1-phosphate-1 receptor agonists: effects of acidic, basic, and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profiles.

  2014cites this paper
• Role of sphingosine 1-phosphate (S1P) and effects of fingolimod, an S1P receptor 1 functional antagonist in lymphocyte circulation and autoimmune diseases

  2014cites this paper
• Synthesis of new 2,5-disubstituted-1,3,4-thiadiazole derivatives and their in vivo anticonvulsant activity

  2014cites this paper
• Structural biology of the S1P1 receptor.

  2014cites this paper
• Synthesis of 2,5‐Diarylpyrroles by Ligand‐Free Palladium‐Catalyzed CH Activation of Pyrroles in Ionic Liquids

  2013cites this paper
• Synthesis of novel 1-[5-(4-methoxy-phenyl)-[1,3,4]oxadiazol-2-yl]-piperazine derivatives and evaluation of their in vivo anticonvulsant activity.

  2013cites this paper
• Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis.

  2012cites this paper
• Discovery of a novel class of zwitterionic, potent, selective and orally active S1P₁ direct agonists.

  2012cites this paper
• Synthesis and SAR of 1,3-thiazolyl thiophene and pyridine derivatives as potent, orally active and S1P₃-sparing S1P₁ agonists.

  2012cites this paper
• Discovery of novel 1,2,4-thiadiazole derivatives as potent, orally active agonists of sphingosine 1-phosphate receptor subtype 1 (S1P(1)).

  2012cites this paper
• Synthetic sphingosine 1-phosphate receptor modulators--opportunities and potential pitfalls.

  2011cites this paper
• Dissecting the Role of the S1P/S1PR Axis in Health and Disease

  2011cites this paper
• Selective mono- to perarylations of tetrabromothiophene by a cyclobutene-1,2-diylbisimidazolium preligand.

  2011cites this paper
• FTY720創薬物語：世界初のスフィンゴシン 1-リン酸受容体調節薬の創製

  2011cites this paper
• Translational aspects of sphingosine 1-phosphate biology.

  2011cites this paper
• Pyrazole derived from (+)-3-carene; a novel potent, selective scaffold for sphingosine-1-phosphate (S1P(1)) receptor agonists.

  2010cites this paper
• Be used for the treatment of the tricyclic acid derivative be substituted as S1P1 receptor stimulant of autoimmune conditions and inflammatory conditions

  2009cites this paper
• Regioselective Palladium(0)‐Catalyzed Cross‐Coupling Reactions and Metal‐Halide Exchange Reactions of Tetrabromothiophene: Optimization, Scope and Limitations

  2009cites this paper
• Ligand-binding pocket shape differences between sphingosine 1-phosphate (S1P) receptors S1P1 and S1P3 determine efficiency of chemical probe identification by ultrahigh-throughput screening.

  2008cites this paper
• Oxadiazolderivat mit Wirkung auf Sphingosin-1-phosphat (s1p)

  2008cites this paper
• Silencing S1P1 Receptors Regulates Collagen‐V Reactive Lymphocyte‐Mediated Immunobiology in the Transplanted Lung

  2008cites this paper
• Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.

  2008cites this paper
• SAR studies of 3-arylpropionic acids as potent and selective agonists of sphingosine-1-phosphate receptor-1 (S1P1) with enhanced pharmacokinetic properties.

  2007cites this paper
• FTY720 Story. Its Discovery and the Following Accelerated Development of Sphingosine 1-Phosphate Receptor Agonists as Immunomodulators Based on Reverse Pharmacology

  2007cites this paper
• Drug Targeting of α-Synuclein Oligomerization in Synucleinopathies

  2007cites this paper
• Chapter 16 Sphingosine 1-Phosphate Type 1 Receptor Modulators: Recent Advances and Therapeutic Potential

  2007cites this paper
• Highly Selective and Potent Agonists of Sphingosine‐1‐phosphate 1 (S1P1) Receptor.

  2006cites this paper
• A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model.

  2006cites this paper